Ignite Creation Date:
2025-12-25 @ 4:28 AM
Ignite Modification Date:
2025-12-26 @ 3:31 AM
Study NCT ID:
NCT03484520
Status:
TERMINATED
Last Update Posted:
2022-12-30
First Post:
2018-03-26
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Study of Venetoclax and Dinaciclib (MK7965) in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Sponsor:
AbbVie
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-07-23
Start Date Type:
ACTUAL
Primary Completion Date:
2022-12-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-12-01
Completion Date Type:
ACTUAL
First Submit Date:
2018-03-26
First Submit QC Date:
None
Study First Post Date:
2018-03-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-12-28
Last Update Post Date:
2022-12-30
Last Update Post Date Type:
ACTUAL